CAROL STANTON
2 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Carol Stanton from Pulmonary Fibrosis News
Scoop.it!

Cigarette Smoking Liked To Interstitial Lung Diseases, IPF

Cigarette Smoking Liked To Interstitial Lung Diseases, IPF | CAROL STANTON | Scoop.it

According to the authors, cigarette smoking leads to an exaggerated accumulation of inflammatory cells in the small airways and interstitium (the tissue and space surrounding the air sacs of the lungs). Smoking also triggers the production of transforming growth factor (TGF)-beta 1, a molecule that plays a central role in the development of lung fibrosis.


Via Bill Vick
Carol Stanton's insight:

A new study recently published in the journal Respirology reviewed the growing evidence of a link between cigarette smokingand the development of interstitial lung diseases (ILD) including idiopathic pulmonary fibrosis (IPF). 

more...
Bill Vick's curator insight, July 27, 2015 10:20 AM

A new study recently published in the journal Respirology reviewed the growing evidence of a link between cigarette smokingand the development of interstitial lung diseases (ILD) including idiopathic pulmonary fibrosis (IPF). 

Rescooped by Carol Stanton from Pulmonary Fibrosis News
Scoop.it!

Idiopathic Pulmonary Fibrosis News - developments in treatment of #IPF

Idiopathic Pulmonary Fibrosis News - developments in treatment of #IPF | CAROL STANTON | Scoop.it

This is really for Physicians but the faculty is amongst the very best of the best ILD Pulmonary Medical Doctors and the publications is on target.

 

 

Faculty Listing:

Harold R. Collard, MD
Associate Professor of Medicine
Director, Interstitial Lung Disease Program
University of California San Francisco
San Francisco, California

Kevin R. Flaherty, MD, MS
Professor of Medicine
Medical Director
Idiopathic Pulmonary Fibrosis Foundation Clinical Care Site
University of Michigan Health System
Ann Arbor, Michigan

Steven D. Nathan, MD
Medical Director
Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Falls Church, Virginia


Via Bill Vick
Carol Stanton's insight:

Idiopathic Pulmonary Fibrosis #IPF: Coverage From Denver


Target Audience:
The target learning audience is a national audience of pulmonologists, primary care physicians, and other clinicians with an interest in idiopathic pulmonary fibrosis (IPF).

Program Overview:
This newsletter activity highlights the latest developments in the treatment of IPF presented at an international conference of pulmonologists held in Denver, Colorado in May 2015.


Learning Objectives:

Review the latest data on treatments for idiopathic pulmonary fibrosis (IPF)Discuss how therapeutic advances in IPF are guiding research into improved care


more...
Bill Vick's curator insight, August 1, 2015 4:52 PM

Idiopathic Pulmonary Fibrosis #IPF: Coverage From Denver


Target Audience:
The target learning audience is a national audience of pulmonologists, primary care physicians, and other clinicians with an interest in idiopathic pulmonary fibrosis (IPF).

Program Overview:
This newsletter activity highlights the latest developments in the treatment of IPF presented at an international conference of pulmonologists held in Denver, Colorado in May 2015.


Learning Objectives:

Review the latest data on treatments for idiopathic pulmonary fibrosis (IPF)Discuss how therapeutic advances in IPF are guiding research into improved care


Vonda Alexander's curator insight, August 1, 2015 10:36 PM

Idiopathic Pulmonary Fibrosis #IPF: Coverage From Denver

 

Target Audience:
The target learning audience is a national audience of pulmonologists, primary care physicians, and other clinicians with an interest in idiopathic pulmonary fibrosis (IPF).

Program Overview:
This newsletter activity highlights the latest developments in the treatment of IPF presented at an international conference of pulmonologists held in Denver, Colorado in May 2015.

 

Learning Objectives:

Review the latest data on treatments for idiopathic pulmonary fibrosis (IPF)Discuss how therapeutic advances in IPF are guiding research into improved care

 

Rescooped by Carol Stanton from Pulmonary Fibrosis News
Scoop.it!

New Drugs for Idiopathic Pulmonary Fibrosis 2015 Top 10 Medical Innovation


Via Bill Vick
more...
No comment yet.
Rescooped by Carol Stanton from Pulmonary Fibrosis News
Scoop.it!

Gene study helps understand pulmonary fibrosis

Gene study helps understand pulmonary fibrosis | CAROL STANTON | Scoop.it
A study of the genomes of more than 1,500 patients with idiopathic pulmonary fibrosis found multiple genetic associations with the disease. One variant in a gene called TOLLIP was linked to an increase in the risk of death.

Via Bill Vick
Carol Stanton's insight:

WE NEED A CURE.................WHAT ABOUT STEM CELL HOW IS THAT COMING ALONG KEEP US ALL POSTED

more...
Bill Vick's curator insight, April 29, 2013 12:02 PM
Genome Study Suggests New Strategies for Understanding and Treating Pulmonary Fibrosis

A new genome-wide association study of more than 6,000 people has identified seven new genetic regions associated with pulmonary fibrosis. In findings published online in Nature Genetics on April 14, 2013, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease.

 
Sheena Jones's comment, June 14, 2013 9:10 AM
ohh thts scary
Rescooped by Carol Stanton from Insurance News
Scoop.it!

HHS Pushes States To Negotiate Lower Obamacare Rates

HHS Pushes States To Negotiate Lower Obamacare Rates | CAROL STANTON | Scoop.it
Healthcare.gov CEO Kevin Counihan is urging state insurance commissioners to look carefully at proposed rate hikes for insurance premiums in 2016.

Via Mike Gattorna
more...
No comment yet.
Rescooped by Carol Stanton from Pulmonary Fibrosis News
Scoop.it!

Pulmonary Fibrosis, Protein and the Need For Good Nutrition

Pulmonary Fibrosis, Protein and the Need For Good Nutrition | CAROL STANTON | Scoop.it
Pulmonary fibrosis is a critical illness that may probably result in growing scarring of the lung tissues. The illness begins with accidents to the tissues, each inside and between the alveoli (tiny air sacs) within the lungs.

Via Bill Vick
more...
Bill Vick's curator insight, June 21, 2015 8:13 AM

What Causes Pulmonary Fibrosis?

 

There are tons of of things that may injury the lungs and result in pulmonary fibrosis, however a few of the commonest embrace:

 

– Environmental or occupational elements: there are a selection of poisons and pollution that you would be able to are available contact with each in your job and every day life. Grain mud, sugar cane and animal droppings may also trigger these issues as nicely.

 

– Radiation: lung injury can happen in people who find themselves given radiation remedy for lung or breast most cancers. This injury might not present up for months and even years, after the primary remedy was achieved. Using chemotherapy also can improve the danger of damages to the lung.

 

– Drugs: sure medicine might be dangerous to the lungs, together with some chemotherapy medicine, some coronary heart drugs, some psychiatric drugs and a few antibiotics.

 

– Gastroesophageal reflux illness, additionally referred to as GERD: when abdomen acids again up into the esophagus, it could result in damages not solely to this construction however to the lungs as properly.

 

– Lung infections and different medical circumstances: some lung illnesses, similar to tuberculosis and pneumonia, can result in the scarring that will increase the danger for pulmonary fibrosis. Different circumstances that may result in this illness: systemic lupus erythematosus, rheumatoid arthritis, dermatomyostitis, poliomyelitis, Sjogren’s syndrome and acidosis. It might even be related to scleroderma.

 
Rescooped by Carol Stanton from Pulmonary Fibrosis News
Scoop.it!

The Role of Aging in Idiopathic Pulmonary Fibrosis. - PubMed - NCBI

The Role of Aging in Idiopathic Pulmonary Fibrosis. - PubMed - NCBI | CAROL STANTON | Scoop.it

Lung. 2015 Apr 23. [Epub ahead of print]


Via Bill Vick
more...
Bill Vick's curator insight, April 26, 2015 9:44 PM
Environmental stress over time caused by the inhalation of foreign substances results in subsequent damage and repair of lung tissue. This damage prematurely causes a decrease in stem cell differentiation potential. In conjunction with declining proliferation, the correlation between age and general attenuation of the immune system allows for the introduction of viral components such as the Epstein-Barr virus which has been associated with lung injury, a causation which has not yet been investigated. But, regardless of environmental factors, cellular alterations due to, or in correlation with, age could result in the onset or prolonging of IPF.